Navigation Links
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Date:4/15/2008

Manufacturing Agreements

AstraZeneca and Ranbaxy have separately entered into an agreement under which Ranbaxy will formulate a significant portion of AstraZeneca's U.S. supply of Nexium from May 2010, including provisions for the manufacture of Esomeprazole magnesium, the Active Pharmaceutical Ingredient (API) from May 2009.

Distribution Agreements

AstraZeneca and Ranbaxy have also entered into two separate agreements designating Ranbaxy as the U.S. distributor for the authorized generic versions of Felodipine Capsules and Omeprazole 40mg Tablets. Ranbaxy will be compensated for its distribution services on standard commercial terms.

In regards to the Distribution Agreements, Mr. Singh added, "It is anticipated that these products will fulfill the needs of the U.S. healthcare system in providing a generic formulation as an option, in addition to the brand. This will support the requirement of patients prescribed these medications, and supports our long-term efforts to increase our product portfolio of generic molecules to meet the needs of Americans."

Esomeprazole magnesium belongs to a class of medicines known as proton-pump inhibitors (PPIs). It works by binding to, and inhibiting, the acid pumps of a particular type of cell, which is found in the stomach. In doing so, it lowers the level of acidity in the stomach and helps to heal erosions in the esophagus or ulcers in the duodenum.

Esomeprazole magnesium is an effective treatment for patients with gastroesophageal reflux disease (GERD), but is particularly appropriate for those suffering from persistent, recurrent GERD, which can cause disruptive, long-term symptoms. Esomeprazole magnesium has been demonstrated to provide enduring relief from the impact of GERD amongst patients.

Felodipine is a calcium antagonist for the treatment of hypertension and angina.

Omeprazole was the first PPI and is used for the short-term treatment of acid-related disea
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
2. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
3. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
4. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
5. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
6. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
8. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
9. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
10. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
11. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , SAN DIEGO, Nov. 20 Ve...tal Award in the mid-size company category at the ...ponsored by the San Diego Society for Human Resour...ional human resources practices. ,, Veridiam wa... employee-nominated companies, honored at the rece...
(Date:11/20/2009)... , , STOCKHOLM, November 20 /PRNew...d that the European Investment Fund (EIF) has ente...y. The co-investment fund will be,managed by Karol...y,s,portfolio of early-stage pharmaceutical and me...st 26.7 M Euros in the co-investment fund. The agr...
(Date:11/20/2009)... , METTLER TOLEDO recentl...nt a free webinar, “The Role of Process Anal...en Engineering” on December 1, 2009. , ...uring the The Role of Process Analytical Technolo...Webinar on December 1, Process Analytical Technol...
(Date:11/19/2009)... , , SEATTLE, Nov. 19 /PRNewswire-FirstCal...nounced unaudited financial results for the third ...nths ended September 30, 2009, Omeros reported a n...mpared to a net loss of $7.4 million, or $2.54 per...months ended September 30, 2009, the Company repor...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...Michael J. Fox plans to visit the Waisman Center i... Jim Doyle and Fox will hold a media event to disc...r biotechnology research in Wisconsin. , ,In Novem... at the forefront of biotechnology and stem cell r...tment, much of it private, in various life-science...
...ut the importance of transparency, which I describ..., political, social and maybe even personal perspe...ion can filter and interpret what we say and write...nd it becomes increasingly important in a growing ...ism, more often than not, do not apply. Both write...
....M. Keck Foundation of Los Angeles has given Univ...llion grant to study how stem-cell cultures remain...ly. , ,Human embryonic stem cells, which lead scie...ustained culture, can propagate essentially foreve... kinds of cells blood, tissue, neurons or anythin...
Other Biology Technology:Michael J. Fox coming to UW Waisman Center 2Corporations and blogging 2Corporations and blogging 3
(Date:11/23/2009)...ing dangers to human health and the environment. N...project with funding from the U.S. Environmental P...ease that contribute to millions of overflows ever...further reduce the risk of sewage spills. , At i...as opposed to "combined" systems that also handle ...
(Date:11/22/2009)...sts have succeeded in producing the polymers used ...er than through the use of fossil fuel based chemi...allow for the production of environmentally consci...urnal Biotechnology and Bioengineering to mark t...olecules found in everyday life in the form of pla...
(Date:11/22/2009)... Pharmaceuticals today announced that its scientis...mutated IDH1 gene has a novel enzyme activity cons...is breakthrough discovery shows that the mutated f...ate (2HG), which may contribute to the formation a...on type of brain cancers. This discovery appears t...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Bioengineers succeed in producing plastic without the use of fossil fuels 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Nations hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 60511 1Nations hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 60511 2Nations hip fracture rate could drop 25 percent with aggressive osteoporosis prevention 60511 3Childhood Brain Cancer Causes Other Long Term Problems 60506 1Childhood Brain Cancer Causes Other Long Term Problems 60506 2Epic Recording Brings Together Latin Artists Under a Common Cause 60502 1Epic Recording Brings Together Latin Artists Under a Common Cause 60502 2Epic Recording Brings Together Latin Artists Under a Common Cause 60502 3
...tham, MACryptosporidium parvum is a tiny yet insid...de. This parasite is a major cause of diarrhea and...tries, and causes severe disease in AIDS and other...d. Cryptosporidium is resistant to water chlorinat...which has led to the concern that the parasite cou...
...mpa, Fla. (Jan. 25, 2008) The American Society f...ill be held May 1-3, 2008 at the Sheraton Sand Key...submitting abstracts is February 1, 2008., Abstra...org and travel and hotel information may be found...versary in 2008, the ASNTR is the pre-eminent soci...
... Baos, Philippines The International Rice Researc...nding to harness major scientific advances and add...culture. IRRIs new project will help develop and d...rown in rainfed ecosystemswhere farmers have littl...ental stresses such as drought, flooding, and sali...
Other Biology News:Breakthrough research turns the tide on water-borne pathogen 2ASNTR 15th anniversary meeting to be held May 1-3 in Florida 2Gates funding to help poor rice farmers 2Gates funding to help poor rice farmers 3Gates funding to help poor rice farmers 4
Goat HRP-DAB Cell & Tissue Staining Kit from R&D Systems
Goat HRP-AEC Cell & Tissue Staining Kit from R&D Systems
...als necessary for the isolation and preparation of...s. Kit Components: Erythrocyte Lysis Buffer -...f buffered ammonium chloride. (NH 4 Cl) Fixation ...aining 220 mL of PBS, formalin, sucrose and 0.5% s...
CultureWell multislip cell culture system MSI-12 *plate and insert fifteen 12 mm coverslips per insert* *set of 10* from Molecular Probes (Invitrogen)
Biology Products: